David Cebrián

Nodal/Activin Signaling Drives Self-Renewal and Tumorigenicity of Pancreatic Cancer Stem Cells and Provides a Target for Combined Drug Therapy

Enza Lonardo, Patrick Hermann, M Mueller et al. · Cell stem cell · 2011 · 412 citations · Full text

Lineage Plasticity, Pancreatic Cancer, Combined Drug Therapy +9

Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition

Susan Wyllie, Stephen Brand, Michael G. Thomas et al. · Proceedings of the National Academy of Sciences · 2019 · 165 citations · Full text

Pharmacological Inhibition of PI3K Reduces Adiposity and Metabolic Syndrome in Obese Mice and Rhesus Monkeys

Ana Ortega-Molina, Elena Lopez-Guadamillas, Julie A. Mattison et al. · Cell Metabolism · 2015 · 93 citations · Full text

Obesity, Metabolic Syndrome, Energy Homeostasis +11

Hit to lead evaluation of 1,2,3-triazolo[4,5-b]pyridines as PIM kinase inhibitors

Joaquı́n Pastor, Julen Oyarzábal, Gustavo Saluste et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 44 citations · Full text

Medicinal Chemistry, Medicine, Rational Drug Design +9

Discovery of novel triazolo[4,3-b]pyridazin-3-yl-quinoline derivatives as PIM inhibitors

Sonia Martı́nez, Sonsoles Rodríguez-Arístegui, Cristina Gómez de la Oliva et al. · European Journal of Medicinal Chemistry · 2019 · 37 citations · Full text

Medicinal Chemistry, Pim Inhibitors, Medicine +6